Company news
Noxopharm Ltd. news in 2022
Noxopharm Ltd.'s news releases, calls and decks from 2022, newest first.
NOX Pipeline Boosted by $1.5M Grant to Hudson Institute
December 15, 2022
September 2022 Quarterly Activities Report and Appendix 4C
October 20, 2022
Novel Dual-cell Therapy Results in Pancreatic Cancer
September 13, 2022
Response to ASX Price Query
September 1, 2022
June 2022 Quarterly Activities Report and Appendix 4C
July 26, 2022
March 2022 Quarterly Activities Report and Appendix 4C
April 27, 2022
FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment
March 29, 2022
Orphan Drug Designation Granted to Noxopharm by US FDA
March 21, 2022
First Patient Treated in CEP-2 Sarcoma Trial
February 27, 2022
Appendix 4D and Half Year 2022 Financial Report
February 21, 2022
December 2021 Quarterly Activities Report and Appendix 4C
January 26, 2022
Noxopharm Receives A$5.865M R & D Tax Rebate
January 6, 2022
Noxopharm Announces Leadership Transition
January 4, 2022
Decks in 2022
- Shareholder Meeting (November 2022)
Shareholder meeting · 31 slides · Nov 17, 2022
- Investor Presentation (June 2022)
Investor deck · 26 slides · Jun 7, 2022